** know ** 3. Federal Law - 18%

Standard Non-Hazardous Stock (2.1 Storage Handling & Disposal): how to dispose non-hazardous?

Applies to normal, uncompromised stock items or shipping components. Disposed of entirely via standard municipal pharmacy waste streams.

P-list Hazardous Classification (2.1 Storage Handling & Disposal)

Governs acutely hazardous commercial chemical wastes. Items cannot be poured down common sinks or placed in regular trash bins.

provide medication names in P-list Common Examples (2.1 Storage Handling & Disposal)

Strictly encompasses specific items like Nicotine; warfarin (Brand: Coumadin) formulations that exceeding 0.3%; and Physostigmine

what is P-list Packaging Rule (2.1 Storage Handling & Disposal)

Mandates that the empty primary container, such as a stock vial, that held a P-listed medication must be treated as independent hazardous waste.

what is U-list Hazardous Classification (2.1 Storage Handling & Disposal)

Covers standard toxic commercial chemical drug products that become legally designated hazardous waste only at the exact moment of disposal.

provide medication names of U-list Common Examples (2.1 Storage Handling & Disposal)

Includes dangerous medical treatments such as Cyclophosphamide (chemotherapy) and Phenol.

Pharmacological Waste Processing (2.1 Storage Handling & Disposal)

Applies to standard, non-hazardous chemical drug waste. Items are set aside in dedicated white or blue pharmacy bins for industrial incineration.

Schedule I (C-I) Criteria (2.2 Controlled Prescription Rules)

High abuse potential paired with a complete lack of currently accepted medical utility in treatment within the United States.

Schedule I (C-I) Examples (2.2 Controlled Prescription Rules)

Includes highly regulated substances such as Heroin and LSD.

Schedule II (C-II) Criteria (2.2 Controlled Prescription Rules)

High abuse potential paired with an accepted medical utility, but carries an extreme risk of severe psychological or physical dependence.

Schedule II (C-II) Refill Law (2.2 Controlled Prescription Rules)

Federal statutory baseline: Refills are completely prohibited. Exactly zero refills can be authorized on a C-II prescription.

Schedule III & IV Refill Law (2.2 Controlled Prescription Rules)

Moderate-to-low abuse risk. Prescriptions are legally restricted to a maximum of 5 refills within 6 months from the date issued.

Schedule V Refill Law (2.2 Controlled Prescription Rules)

Lowest abuse profile under the CSA. Refills are authorized by the prescriber but remain subject to varying state-level restrictions.

Emergency C-II Phone Orders (2.2 Controlled Prescription Rules)

Restricted to immediate emergency scenarios where no alternative exists. Prescribers must deliver a valid signed prescription within 7 days.

Controlled Script Transfer Limit (2.2 Controlled Prescription Rules)

Schedule III through V medications can be physically or electronically transferred between pharmacies exactly one time total.

Real-Time Database Exception (2.2 Controlled Prescription Rules)

Pharmacies sharing a unified, real-time electronic database can transfer Schedule III through V prescriptions up to the maximum refills permitted by law.

C-II Physical Receiving Standard (2.3 Controlled Substance Logistics)

Requires immediate, direct physical count verification and validation by a licensed pharmacist before the drug enters stock.

Controlled Stock Storage Options (2.3 Controlled Substance Logistics)

Must be locked inside a securely anchored safe/cabinet or structurally dispersed throughout non-controlled inventory to prevent internal theft.

DEA Form 222 Application (2.3 Controlled Substance Logistics)

Mandatory paper triplicate, single-sheet form, or electronic CSOS transmission required to buy, transfer, or distribute Schedule II items.

C-III to C-V Ordering Standard (2.3 Controlled Substance Logistics)

Form 222 is not used. Procurement utilizes standard wholesale invoices that must be signed, dated, and stored separately.

Federal Warning Label Target (2.3 Controlled Substance Logistics)

Legally mandated for all filled prescription vials belonging to Schedule II, Schedule III, and Schedule IV medications.

Federal Warning Label Phrase (2.3 Controlled Substance Logistics)

Exact legal text required: "Caution: Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed."

Authorized Reverse Distributors (2.3 Controlled Substance Logistics)

Licensed external entities legally permitted to receive, log, and destroy expired or unusable pharmacy controlled substances.

DEA Form 41 Application (2.3 Controlled Substance Logistics)

The formal inventory document required to officially report the destruction of controlled substances.

DEA Form 106 Timing Standard (2.3 Controlled Substance Logistics)

Pharmacies must notify the DEA in writing within one business day of discovering a significant loss or theft.

DEA Form 106 Application (2.3 Controlled Substance Logistics)

The official administrative document submitted to report theft details or significant inventory missingness to the DEA.

CMEA Daily Purchasing Limit (2.4 Restricted Drug Programs)

Restricts over-the-counter sales of pseudoephedrine to a maximum of 3.6 grams per calendar day per individual purchaser.

CMEA Monthly Purchasing Limit (2.4 Restricted Drug Programs)

Restricts retail and mail-order pseudoephedrine to a combined maximum of 9.0 grams within any rolling 30-day window.

CMEA Verification Mandates (2.4 Restricted Drug Programs)

Requires the purchaser to show valid photo identification and log their name, address, date, and time with a signature.

iPLEDGE REMS Objective (2.4 Restricted Drug Programs)

A high-alert safety program implemented for isotretinoin to prevent severe fetal exposure and major birth defects.

iPLEDGE REMS Mandates (2.4 Restricted Drug Programs)

Requires female patients to complete pregnancy testing and follow required pregnancy-prevention measures.

Clozaril REMS Objective (2.4 Restricted Drug Programs)

A specialized safety monitoring program for clozapine prescriptions to proactively detect blood toxicity.

Clozaril REMS Mandates (2.4 Restricted Drug Programs)

Tracks and monitors a patient's absolute neutrophil count (ANC) values to protect against severe neutropenia/agranulocytosis.

Class I Recall Severity (2.5 FDA Medication Recalls)

The highest danger tier: Urgent alerts for defective or mislabeled drugs that present a high risk of serious health harm or death.

Class I Recall Example (2.5 FDA Medication Recalls)

Occurs when a dangerous medication is accidentally bottled or mislabeled under an incorrect drug name.

Class II Recall Severity (2.5 FDA Medication Recalls)

Moderate danger tier: Issued for products that can cause temporary or medically reversible health issues with low risk of permanent harm.

Class II Recall Example (2.5 FDA Medication Recalls)

Typically triggered by a manufacturer batch found to be slightly sub-potent or containing minor non-toxic contaminants.

Class III Recall Severity (2.5 FDA Medication Recalls)

Lowest danger tier: Issued for product defects that are unlikely to cause adverse medical consequences.

Class III Recall Example (2.5 FDA Medication Recalls)

Triggered by localized cosmetic outer packaging deformities or minor informational errors on the container label.

DSCSA Serialization Barcode (2.6 Serialization Tracking & Tracing)

Unique 2D data matrix code on stock packages containing product identification, serial number, lot number, and expiration date.

Transaction Information (TI) (2.6 Serialization Tracking & Tracing)

Part of the 3 Ts: Details the name of the drug, strength, dosage form, NDC, package size, lot number, and transaction dates.

Transaction History (TH) (2.6 Serialization Tracking & Tracing)

Part of the 3 Ts: A chronological statement tracing changes of ownership back through the pharmaceutical supply chain.

Transaction Statement (TS) (2.6 Serialization Tracking & Tracing)

Part of the 3 Ts: A compliance statement confirming that the transferring entity met applicable DSCSA tracing requirements.

Suspect Product Quarantine Rule (2.6 Serialization Tracking & Tracing)

Any medication suspected of being counterfeit, altered, or stolen must be removed from stock and appropriately quarantined while investigated.

Controlled Substances Act (CSA) of 1970 (Controlled Substance Regulations & Schedules)

Classifies controlled drugs into five schedules (C-I through C-V) based on medical use and abuse/dependence potential and establishes federal controlled-substance requirements.

DEA Form 224 (Controlled Substance Documentation & Registration)

Registration form used by pharmacies and other authorized entities to register with the DEA as controlled-substance handlers. DEA registration generally requires periodic renewal.

Controlled Substance Record Retention Rule (Controlled Substance Documentation & Registration)

Federal requirements establish retention periods for controlled-substance records, including inventories, invoices, prescriptions, and related documentation.

DEA Number Verification Rule (Controlled Substance Verification)

A mathematical checksum is used to verify whether a DEA registration number is structurally valid: add the 1st, 3rd, and 5th digits to twice the sum of the 2nd, 4th, and 6th digits; the final digit should match the 7th digit.

Food, Drug, and Cosmetic Act (FDCA) of 1938 (General Federal Pharmacy Legislation)

Established the federal framework for drug safety, adulteration, and misbranding and strengthened federal regulation of drugs and pharmaceuticals.

Durham-Humphrey Amendment of 1951 (General Federal Pharmacy Legislation)

Established the distinction between prescription (legend) drugs and over-the-counter (OTC) drugs and established requirements for prescription labeling.

Kefauver-Harris Amendment of 1962 (General Federal Pharmacy Legislation)

Required manufacturers to demonstrate drug efficacy in addition to safety before marketing approval.

Poison Prevention Packaging Act (PPPA) of 1970 (Packaging and Dispensing Regulations)

Established requirements for child-resistant packaging for many prescription and household substances, with specified exemptions.

Omnibus Budget Reconciliation Act (OBRA '90) (Dispensing Regulations & Patient Care)

Established federal requirements for Medicaid pharmacy services including prospective drug utilization review and pharmacist counseling requirements.

Health Insurance Portability and Accountability Act (HIPAA) of 1996 (Patient Privacy & Information Security)

Protects the privacy and security of protected health information and regulates its use and disclosure.

OSHA Regulations (Workplace Safety & Waste Management)

Establish workplace safety requirements relevant to pharmacy personnel, including protection from bloodborne pathogens and hazardous chemical exposures.

USP Chapter

Establishes standards for nonsterile pharmaceutical compounding.

USP Chapter

Establishes standards for sterile pharmaceutical compounding to reduce contamination and patient harm.

USP Chapter

Establishes standards for handling hazardous drugs to protect personnel, patients, and the environment.